Barclays PLC Icad Inc Transaction History

Barclays PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.02 - $4.56 $10,739 - $16,215	-3,556 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.92 - $7.48 $90,222 - $172,159	-23,016 Reduced 86.62%	3,556 $16,000
Q4 2021 Feb 14, 2022	SELL	$6.7 - $11.38 $176,712 - $300,147	-26,375 Reduced 49.81%	26,572 $192,000
Q3 2021 Nov 09, 2021	BUY	$10.11 - $17.56 $505,692 - $878,333	50,019 Added 1708.3%	52,947 $570,000
Q2 2021 Aug 13, 2021	SELL	$14.9 - $20.82 $206,782 - $288,939	-13,878 Reduced 82.58%	2,928 $51,000
Q1 2021 May 13, 2021	BUY	$12.57 - $21.22 $129,672 - $218,905	10,316 Added 158.95%	16,806 $357,000
Q4 2020 Feb 11, 2021	SELL	$8.73 - $14.56 $46,478 - $77,517	-5,324 Reduced 45.07%	6,490 $86,000
Q3 2020 Nov 12, 2020	BUY	$8.56 - $11.6 $6,676 - $9,048	780 Added 7.07%	11,814 $104,000
Q2 2020 Aug 12, 2020	BUY	$6.63 - $12.85 $73,155 - $141,786	11,034 New	11,034 $110,000
Q4 2019 Feb 10, 2020	SELL	$6.23 - $7.98 $37 - $47	-6 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.62 - $7.86 $33 - $47	6 New	6 $0

5.47M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $44.8M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.